This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.from Top Business News- News18.com https://ift.tt/3cb6mFS
Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir
This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.from Top Business News- News18.com https://ift.tt/3cb6mFS
Related Posts
Gold firms on weaker dollar as focus turns to Fed
Virus pandemic reshaping air travel as carriers struggle
Petrol Prices on the Rise While Diesel Rates Remains Steady as Economic Activity Remains Muted
Sanofi snags another U.S. biotech asset with $3.7 billion deal for Principia Biopharma
Global Markets: Asia shares set to follow Wall Street's tech-driven rally
0 comments: